Page URL: https://www.bionews.org.uk/page_95161

Gene therapy restores sight in mice

24 August 2015
Appeared in BioNews 816

An experimental form of gene therapy to treat blindness has been showed to restore some vision in mice.

Researchers from the University of Manchester were able to generate a response to visual stimuli in mice with advanced retinal degeneration by enabling other cells in the eye to capture light.

They used a virus to insert a gene that produces the light-sensing pigment, rhodopsin, into the ganglion and bipolar cells in the eye, usually responsible for transmitting electronic signals from the rods and cones to the brain.

After treatment, the mice were reported to react when shown a video of an owl swooping. 'You could say they were trying to escape, but we don't know for sure', said Professor Rob Lucas of the University of Manchester and co-author of the study. 'What we can say is that they react to the owl in the same way as sighted mice, whereas the untreated mice didn't do anything.'

The mice were observed to see real objects again, although not so well as sighted mice. 'The treated mice could discriminate black and white bars, but only ones that were 10 times thicker than what sighted mice could see,' Professor Lucas said.

Previous studies have focused on replacing or repairing genes in rods and cones, but the new research attempts to allow other cells in the retina to capture light, compensating for lost light receptors, and could be used to treat certain types of blindness.

Lucas adds that the virus used is already approved for treatment in humans and hopes to start conducting clinical trials in humans in five years' time.

'This is the most effective example yet of the use of genetic therapy to treat advanced retinal degeneration,' Professor Robin Ali of University College London, told New Scientist. Professor Ali was involved in the gene therapy trial for Leber congenital amaurosis, an inherited condition, but was not involved in the new study.

The long-term effects of the treatment are unknown, however. Robert Lanza, chief scientific officer at Ocata Therapeutics, told New Scientist there is some evidence that improvements made in the vision of people with Leber congenital amaurosis treated with gene therapy between one and three years ago has begun to wane.

SOURCES & REFERENCES
A Cure For Blindness May Be In Sight Thanks To Vision Cell-Restoring Gene Therapy
Tech Times |  18 August 2015
Gene therapy cures blindness by replacing vision cells in eyes
New Scientist |  14 August 2015
Redirecting Gene Therapy Restores Sight
The Scientist |  17 August 2015
Restoration of Vision with Ectopic Expression of Human Rod Opsin
Current Biology |  17 August 2015
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
16 October 2017 - by Rikita Patel 
The US Food Drug and Administration advisory committee has backed the use of gene therapy to treat a hereditary disease for the first time...
9 October 2017 - by Dr Kimberley Bryon-Dodd 
Gene therapy has restored some vision in mice blinded by retinitis pigmentosa, an inherited degenerative eye disease...
3 May 2016 - by Sarah Gregory 
A trial of gene therapy for choroideremia, a rare form of inherited blindness, has partially restored the vision of several patients...
13 July 2015 - by Dr Greg Ball 
A technique that delivers genes into the inner ears of mice has been used to restore hearing, marking the first time that gene therapy has been successfully used to treat deafness...
5 May 2015 - by Dr Greg Ball 
Retinal cells derived from human embryonic stem cells have been successfully transplanted into four Korean patients with macular degeneration...
27 April 2015 - by Isobel Steer 
Six boys with the inherited immune disorder Wiskott-Aldrich Syndrome (WAS) have been successfully treated with a gene-therapy technique that harnesses a 'tamed' HIV virus...
15 December 2014 - by Dr Rosie Gilchrist 
Scientists have used gene therapy to restore some sight to animals with visual impairment similar to retinosa pigmentosa, a type of human blindness...
20 October 2014 - by Jenny Sharpe 
Retinal cells derived from human embryonic stem cells have been safely transplanted into the eyes of patients with currently incurable sight loss...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.